Moroni F, Shah KB, Quader MA, Klein K, Smallfield MC, Parris KE, Gertz ZM. Percutaneous approach to left ventricular assist device decommissioning.
Catheter Cardiovasc Interv 2022;
100:169-174. [PMID:
35579199 PMCID:
PMC9543180 DOI:
10.1002/ccd.30230]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Revised: 04/26/2022] [Accepted: 05/03/2022] [Indexed: 11/11/2022]
Abstract
OBJECTIVE
To assess the outcomes of a single-center experience with percutaneous left ventricular assist device (LVAD) decommissioning.
BACKGROUND
Patients with LVADs may eventually require their removal, either due to recovery of left ventricular function or recurrent complications. Traditionally, withdrawal of LVAD support has been managed with surgical device explantation, which carries significant procedural risks. Transcatheter LVAD decommissioning, with outflow graft occlusion and driveline transection, has recently been described as an alternative to surgical removal.
METHODS
Here, we report on a retrospective cohort of five consecutive cases treated with transcatheter LVAD decommissioning.
RESULTS
The procedure was effective in all cases, and no patient experienced procedure-related complications. At midterm follow-up, the three patients who had myocardial function recovery were alive and had not experienced heart failure-related symptoms or complications.
CONCLUSION
Percutaneous LVAD decommissioning appears to be a safe and effective approach to LVAD treatment discontinuation.
Collapse